peptide elongation factor 2 has been researched along with Colonic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, NJ; Liu, Z; Park, YS; Vasamsetti, BMK | 1 |
| Gao, D; Li, JJ; Ma, X; Niu, A; Sun, W; Wei, X | 1 |
2 other study(ies) available for peptide elongation factor 2 and Colonic Neoplasms
| Article | Year |
|---|---|
Muscarinic acetylcholine receptors regulate the dephosphorylation of eukaryotic translation elongation factor 2 in SNU-407 colon cancer cells.
Topics: Cell Line, Tumor; Colonic Neoplasms; Humans; Peptide Elongation Factor 2; Phosphoprotein Phosphatases; Phosphorylation; Protein Kinase C; Receptors, Muscarinic; Signal Transduction | 2019 |
Enhanced anti-colon cancer immune responses with modified eEF2-derived peptides.
Topics: Animals; Caco-2 Cells; Colonic Neoplasms; Cytotoxicity, Immunologic; HLA-A2 Antigen; Humans; Immunologic Factors; Immunotherapy, Adoptive; Mice, Inbred C57BL; Mice, Nude; Mice, Transgenic; Neoplasm Transplantation; Peptide Elongation Factor 2; Peptide Fragments; Protein Binding; T-Lymphocytes, Cytotoxic | 2015 |